Comparison of efficacy, safety, and tolerability of neoral vs sandimmun in de novo renal transplant patients over 24 months' treatment
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 275-276
- https://doi.org/10.1016/s0041-1345(96)00091-7
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patientsTransplant International, 1994
- CYCLOSPORINE PHARMACOKINETICS AND VARIABILITY FROM A MICROEMULSION FORMULATION—A MULTICENTER INVESTIGATION IN KIDNEY TRANSPLANT PATIENTSTransplantation, 1994
- PHARMACOKINETICS AND TOLERABILITY OF A MICROEMULSION FORMULATION OF CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS—A CONCENTRATION-CONTROLLED COMPARISON WITH THE COMMERCIAL FORMULATIONTransplantation, 1994
- Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantationClinical Pharmacology & Therapeutics, 1993